financetom
Business
financetom
/
Business
/
Update: Market Chatter: Boyd Gaming Reaches Out to Penn Entertainment for Merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Boyd Gaming Reaches Out to Penn Entertainment for Merger
Jun 20, 2024 3:00 PM

05:36 PM EDT, 06/20/2024 (MT Newswires) -- (Updates with Penn Entertainment's ( PENN ) response.)

Penn Entertainment ( PENN ) surged 10% in Thursday's regular session after it was approached by rival Boyd Gaming ( BYD ) about a potential merger, Reuter reported Thursday, citing people familiar with the matter.

There is no certainty Penn will engage in talks, the sources told the news outlet. A deal could value Penn at as much as $9 billion, including debt, while Boyd would have a market value of around $7.8 billion, including debt, according to the report.

Penn Entertainment ( PENN ) declined to comment when contacted by MT Newswires, while Boyd Gaming ( BYD ) did not immediately respond. Boyd shares finished the trading session 2% lower.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 20.09, Change: +0.05, Percent Change: +0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
Mar 8, 2024
(Reuters) - The U.S. FDA has approved Novo Nordisk's Wegovy for use in lowering the risk of stroke and heart attack in overweight or obese adults who are not diabetic, the Danish drugmaker said on Friday. Novo's widely used diabetes drug Ozempic and weight-loss drug Wegovy, both chemically known as semaglutide, belong to a class of drugs called GLP-1 agonists....
CSP Shares Fall After Company Affirms Trading on Post-Split Basis March 21
CSP Shares Fall After Company Affirms Trading on Post-Split Basis March 21
Mar 8, 2024
02:17 PM EST, 03/08/2024 (MT Newswires) -- CSP (CSPI) shares fell 6.8% in recent Friday trading after the company affirmed its stock is expected to trade on a post-split basis at the market open on March 21. The shares under the company's 2-for-1 stock split, announced on Feb. 21, will be distributed from the transfer agent on March 20, according...
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
Mar 8, 2024
02:20 PM EST, 03/08/2024 (MT Newswires) -- AutoCanada's ( AOCIF ) Q4/23 headline EPS miss was due to unusual items in opex and higher-than-forecast underlying opex. The other parts of ACQ's Canadian business performed largely in line with BMO's expectations. The stock is trading at 6x BMO's revised 2025E EBITDA vs. historical range of 6-8x. Analyst Tamy Chen wonders if...
Genesco Shares Decline Following Q4 Earnings Report
Genesco Shares Decline Following Q4 Earnings Report
Mar 8, 2024
02:18 PM EST, 03/08/2024 (MT Newswires) -- Genesco ( GCO ) shares were down more than 11% in recent Friday trading following the company's fiscal Q4 earnings report. The company reported fiscal Q4 adjusted earnings of $2.59 per share, down from $3.06 a year ago. Two analysts polled by Capital IQ expected $2.62. Net sales for the quarter ended Feb....
Copyright 2023-2026 - www.financetom.com All Rights Reserved